Measurement of subclinical atherosclerosis: beyond risk factor assessment

被引:30
|
作者
Bisoendial, RJ
Hovingh, GK
de Groot, E
Kastelein, JJP
Lansberg, PJ
Stroes, ESG
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Core Lab Cardiovasc Imaging, NL-1105 AZ Amsterdam, Netherlands
关键词
subclinical atherosclerosis; surrogate end-points; prevention; cardiovascular disease; risk factor management;
D O I
10.1097/00041433-200212000-00002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review Assessment of subclinical atherosclerosis using the current available noninvasive imaging modalities holds promise for individual cardiovascular risk management and monitoring efficacy of therapeutic interventions (i.e. surrogate end-points). The present review addresses benefits and limitations of flow-mediated dilatation, intima-media thickness, electron-beam computed tomography and magnetic resonance coronary angiography. Recent findings Both carotid intima-media thickness and peripheral flow-mediated dilatation correlate inversely with cardiovascular risk factors and coronary artery disease. They have been shown to carry predictive value for future cardiovascular events, but clinical application of both intima-media thickness and flow-mediated dilatation demands further methodological maturation of these techniques. Intima thickening has been successfully targeted in numerous intervention trials, but determination of an explicit threshold value beyond which cardiovascular risk significantly increases will facilitate its utility as a routine clinical tool. Electron-beam computed tomography can accurately detect and quantify coronary artery calcification (an established marker of the total coronary plaque burden). However, lack of evidence of its additional predictive power for future coronary events warrants for further research. Finally, magnetic resonance coronary angiography appears to be a promising technique, integrating both functional and anatomical aspects of coronary artery disease. Properly designed studies are needed to determine its value in clinical practice. Summary Various noninvasive imaging techniques have recently emerged that may find applications in clinical research. However, before widespread clinical utilization, further technical refinement of all of the cited imaging modalities is mandatory. It will be a challenge over the coming few years to clarify whether improvements in surrogate end-points can directly be translated into improved outcomes.
引用
收藏
页码:595 / 603
页数:9
相关论文
共 50 条
  • [1] Prediabetes is not a risk factor for subclinical coronary atherosclerosis
    Park, Gyung-Min
    Cho, Young-Rak
    Lee, Seung-Whan
    Yun, Sung-Cheol
    Won, Ki-Bum
    Ann, Soe Hee
    Kim, Yong-Giun
    Kim, Shin-Jae
    Roh, Jae-Hyung
    Kim, Young-Hak
    Yang, Dong Hyun
    Kang, Joon-Won
    Lim, Tae-Hwan
    Jung, Chang Hee
    Koh, Eun Hee
    Lee, Woo Je
    Kim, Min-Seon
    Lee, Ki-Up
    Park, Joong-Yeol
    Kim, Hong-Kyu
    Choe, Jaewon
    Lee, Sang-Gon
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 479 - 484
  • [2] Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals
    Park, Sangwoo
    Park, Gyung-Min
    Ha, Jinhee
    Cho, Young-Rak
    Roh, Jae-Hyung
    Park, Eun Ji
    Yang, Yujin
    Won, Ki-Bum
    Ann, Soe Hee
    Kim, Yong-Giun
    Kim, Shin-Jae
    Lee, Sang-Gon
    Yang, Dong Hyun
    Kang, Joon-Won
    Lim, Tae-Hwan
    Kim, Hong-Kyu
    Choe, Jaewon
    Lee, Seung-Whan
    Kim, Young-Hak
    PLOS ONE, 2020, 15 (04):
  • [3] Risk factors and assessment of subclinical atherosclerosis in patients with psoriatic arthritis
    Zheng, Zhoulan
    Liu, Qianru
    Zhang, Zhenan
    Guo, Qianyu
    Zhang, Liyun
    Zhang, Gailian
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2024, 36 (06): : 333 - 340
  • [4] Assessment of Subclinical Atherosclerosis in Smokers Does Lower Risk Mean Low Risk?
    Miedema, Michael D.
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (09) : 1818 - 1820
  • [5] Comparison of risk scores to predict subclinical atherosclerosis
    Moreyra Jr, Eduardo
    Lorenzatti, Daniel
    Moreyra, Camila
    Arias, Viviana
    Tibaldi, Miguel A.
    Lepori, Augusto J.
    Sarmiento, Pablo
    Moreyra, Eduardo A.
    MEDICINA-BUENOS AIRES, 2019, 79 (05) : 373 - 383
  • [6] Metabolically healthy obesity and the risk for subclinical atherosclerosis
    Kim, Tae Jun
    Shin, Hee-Young
    Chang, Yoosoo
    Kang, Mira
    Jee, Jaehwan
    Choi, Yoon-Ho
    Ahn, Hyeon Seon
    Ahn, Soo Hyun
    Son, Hee Jung
    Ryu, Seungho
    ATHEROSCLEROSIS, 2017, 262 : 191 - 197
  • [7] Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
    Poznyak, Anastasia V.
    Sadykhov, Nikolay K.
    Kartuesov, Andrey G.
    Borisov, Evgeny E.
    Melnichenko, Alexandra A.
    Grechko, Andrey V.
    Orekhov, Alexander N.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Is self-reported insomnia a risk factor for subclinical carotid atherosclerosis?
    Korostovtseva, Lyudmila
    Alieva, Asiiat
    Rotar, Oxana
    Bochkarev, Mikhail
    Boyarinova, Maria
    Zvartau, Nadejda
    Sviryaev, Yurii
    Konradi, Aleksandra
    Shlyakhto, Evgeny, V
    ARTERIAL HYPERTENSION, 2019, 23 (02): : 105 - 113
  • [9] Primary Sjogren's syndrome as independent risk factor for subclinical atherosclerosis
    Novella-Navarro, Marta
    Luis Cabrera-Alarcon, Jose
    Luis Rosales-Alexander, Jose
    Juan Gonzalez-Martin, Jorge
    Carrion, Ofelia
    Garcia de la Pena, Paloma
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (01) : 20 - 25
  • [10] Subclinical Atherosclerosis and Relationship With Risk Factors of Coronary Artery Disease in a Rural Population
    Mamudu, Hadii M.
    Paul, Timir
    Veeranki, Sreenivas P.
    Wang, Liang
    Panchal, Hemang B.
    Budoff, Matthew
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 350 (04) : 257 - 262